Novel therapies for metastatic prostate cancer.
Albert JangSree M LankaHui Ting RuanHamsa L S KumarAngela Y JiaJorge A GarciaOmar Y MianPedro C BarataPublished in: Expert review of anticancer therapy (2023)
The future for patients with metastatic prostate cancer is promising, with further development of novel therapies such as radiopharmaceuticals. Based on a growing understanding of prostate cancer biology, novel agents are being designed to overcome resistance to approved therapies. There are many trials using novel agents either as monotherapy or in combination with already approved agents with potential to further improve outcomes for men with advanced prostate cancer.